VRTX fund manager activity
Vertex Pharmaceuticals Incorporated · Nasdaq. Reported by 12 tracked fund managers in their 13F filings, Q2 2013 to Q2 2026.
Q4 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ron Baron - Baron Capital | No change | 5,200 | $2,357,472 | 0.01% | Feb 17, 2026 |
| Ken Fisher - Fisher Asset Management | Trimmed | 25,218 | $11,432,860 | 0.00% | Feb 9, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 21,511 | $9,752,227 | 0.04% | Feb 17, 2026 |
| Torray Funds | Trimmed | 15,466 | $7,011,666 | 1.00% | Jan 28, 2026 |
| Tweedy Browne | Added | 39,148 | $17,748,137 | 1.43% | Feb 3, 2026 |
Q3 2025
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ron Baron - Baron Capital | Trimmed | 5,200 | $2,036,528 | 0.01% | Nov 14, 2025 |
| Ken Fisher - Fisher Asset Management | Added | 25,959 | $10,166,863 | 0.00% | Nov 12, 2025 |
| Joel Greenblatt - Gotham Asset Management | Added | 21,888 | $8,572,216 | 0.04% | Nov 14, 2025 |
| Torray Funds | Trimmed | 16,255 | $6,366,108 | 0.86% | Oct 22, 2025 |
| Tweedy Browne | Added | 39,065 | $15,299,417 | 1.33% | Nov 20, 2025 |
Newer quarters · Older quarters